Cognitive & Neuroprotection
P21
P21, also written P021, is a short fragment taken from ciliary neurotrophic factor, one of the natural signals that keeps nerve cells alive; it is sold for memory, motor learning and recovery after head injury. Its evidence is entirely in mice, and the models are interesting ones — Alzheimer's disease, Down syndrome, traumatic brain injury — with a 2026 study using diffusion magnetic resonance imaging to detect the brain microstructure changes it produced. There is a substitution buried inside the strongest of them: the molecule actually given to those mice was Peptide 6, the longer fragment P21 is cut from, not P21 itself. No human has received either.
Last updated
Mechanism
Associated with BDNF up-regulation and synaptic plasticity enhancement.
Reported effects
What sources associate with this compound. Reported categories, not outcomes we have graded — each would need its own citation and rung.
- Motor learning
- Neuroplasticity
- Post-TBI recovery
Dosing on file unverified
100-500 mcg daily, cycled 4–8 weeks
| Reported dose | Volume | Draw |
|---|---|---|
| Low — 100 mcg | 0.1 mL | 10 units |
| High — 500 mcg | 0.5 mL | 50 units |
What that assumes. Assumes 2 mg in 2 mL (1000 mcg/mL) drawn on a U-100 barrel — the preset on this record, not a recommendation and not the only way to mix it. Change the vial mass, the diluent or the barrel and every number in this table changes. Run your own.
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
What is circulated about this dose. 3 claims are recorded on this page with the pages they were read from, and one contradicts the figure above. Read what is circulated.
Reconstitution
| Vial | Diluent | Concentration | Typical dose | Draw |
|---|---|---|---|---|
| 2 mg | 2 mL | 1000 mcg/mL | 100 mcg | 10 units |
mass ÷ diluent = concentration; dose ÷ concentration = volume; volume × the syringe factor = units on the barrel (100 for U-100, 40 for U-40). Run your own numbers.
Literature on file 6
-
animal in vivo
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder. graded on: an animal model — read from the indexed abstract — “mice”
- animal in vivo
-
animal in vivo
Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction. graded on: an animal model — read from the indexed abstract — “mice”
-
animal in vivo
Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice. graded on: an animal model — “mice”
-
animal in vivo
Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound. graded on: an animal model — read from the indexed abstract — “Mice”
-
animal in vivo
Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome. graded on: an animal model — “mouse”
What is circulated not evidence 5
Claims passed around in community guides and vendor copy, recorded because they circulate — not because they are true. Each is shown with the page it was read from and what this record actually holds. Checked 2026-08-24.
-
Roughly 500 mcg to 1 mg once daily is the most-repeated dose, within a broader cited range of about 100 mcg to 2 mg a day, and one guide states every value is anecdotal and vendor-derived.
every value is anecdotal and vendor-derived.
On the record The record holds 100-500 mcg per administration daily, and marks it unverified. The lower bounds agree; the circulated upper bound of 2 mg is four times the maximum on file. The record's dosing has no cited source, and molecular weight, formula, CAS number, sequence and half-life are all not on file.
-
Intranasal administration is widely recommended over injection on the grounds of direct nose-to-brain delivery, while the original rodent studies used oral and peripheral dosing.
There is no clinically established dose, because no human clinical trial has ever defined one.
On the record No route is on file for p21, and the record names that absence rather than papering over it. The community has filled the gap with a route that does not match the animal studies the compound's grading rests on.
-
Sleep disruption or overstimulation is the most frequent community complaint, which is why morning-only dosing is advised; injection-site reactions and headache are also reported.
sleep disruption or overstimulation
On the record No side effect is on file for p21. The single most-reported effect in the community, and the timing rule derived from it, has no entry in the record.
-
A specific reconstitution recipe circulates: a 5 mg vial in 2 to 2.5 mL of bacteriostatic water, giving about 0.20 mL for a 500 mcg dose, or 25 units daily for a ten-day course.
~0.20 mL
On the record Nothing on file. The record holds no reconstitution or storage entry for p21. A ten-day course also conflicts with the 4-8 week cycle on file.
-
Courses of four to eight weeks with time off are the community convention.
4-8 weeks, with time off
On the record The record holds a cycle of 4 to 8 weeks, matching exactly. Neither the record nor the community can name a study behind those numbers; the record's grading rests on an animal model.
Identity
Classified as
- BDNF/TrkB Signalingmechanism
- Nearly every nootropic record on the site points here, so it is where a cognitive claim can be checked against something measurable instead of taken as a description of how someone felt.
- Neuroplasticitypathway
- Nearly every nootropic claim reduces to a claim about this pathway, and the supporting measurement is usually a protein level in rodent brain tissue, an animal_in_vivo finding that does not carry across to human cognition.
Also called
- P21
Not on file 10
8 of the 8 fields we track hold nothing on this record, and each says why. 2 further absences are named below. A blank field is a bug; a named absence is a finding.
- molecular weightno source on file holds this
- molecular formulano source on file holds this
- CAS registry numberthe reference database returned nothing for it
- PubChem identifierno source on file holds this
- amino-acid sequenceno source on file holds this
- SMILES stringthe reference database returned nothing for it
- InChIthe reference database returned nothing for it
- InChI keythe reference database returned nothing for it
- half-lifenothing we hold supplies it
- route of administrationnothing we hold supplies it
Each field links to every other record missing the same thing. The full ledger holds 765 gaps across 163 records.
Listed prices 47
What 33 shops we track listed for P21, read from their own public catalogues on 2026-09-14. We take no commission on these and they are not ranked by any payment — how vendors are scored.
Compare prices47 listings from 33 shops
| Vendor | Size | Price | Per mg |
|---|---|---|---|
| Evolve BioPep | 12 mg | $59.99 USD | $5.00/mg |
| research1peptides | 20 mg | $110.00 USD | $5.50/mg |
| Umbrella Labs | 25 mg | $150.99 USD | $6.04/mg |
| PeptiFy Labs | 10 mg | $75.99 USD |
$7.60/mg |
| Soma Chems | 10 mg | $84.99 USD | $8.50/mg |
| Modern Aminos | 10 mg | $98.00 USD | $9.80/mg |
| atomiklabz | 12 mg | $119.00 USD | $9.92/mg |
| GenX Peptides | 5 mg | $50.00 USD | $10.00/mg |
| Peptides.GG | 10 mg | $110.00 USD | $11.00/mg |
| Protide Health | 10 mg | $110.00 USD | $11.00/mg |
| Pure Health Peptides (GLP Supplies) | 10 mg | $119.00 USD | $11.90/mg |
| Verified Peptides | 10 mg | $119.00 USD | $11.90/mg |
| Grey Research Peptides | 5 mg | $60.00 USD | $12.00/mg |
| Peptide Works | 5 mg | $61.79 USD | $12.36/mg |
| Paramount Peptides | 10 mg | $127.50 USD | $12.75/mg |
| Peptide Works | 2 mg | $30.11 USD | $15.05/mg |
| Nationwide Peptides | 5 mg | $97.00 USD | $19.40/mg |
| Liberty Peptides | 5 mg | $99.00 USD | $19.80/mg |
| Alpha Omega Peptide | 10 mg | $198.00 USD | $19.80/mg |
| SimplePeptide | 10 mg | $198.00 USD | $19.80/mg |
| Raw Amino | 5 mg | $110.00 USD | $22.00/mg |
| Swiss Chems ships worldwide | 5 mg | $114.95 USD | $22.99/mg |
| Core Peptides | 5 mg | $116.00 USD | $23.20/mg |
| USA Peptide Sciences | 5 mg | $120.00 USD | $24.00/mg |
| Nootropic Source | size not listed | $29.95 USD | — |
| Nootropic Source | size not listed | $50.00 USD | — |
| Nootropic Source | size not listed | $64.95 USD | — |
| Vendor | Size | Price | Per mg |
|---|---|---|---|
| Be Better Peptides | 10 mg | £24.99 GBP | £2.50/mg |
| Direct Peptides Canada | 5 mg | £51.01 GBP | £10.20/mg |
| Direct Peptides USA | 5 mg | £51.01 GBP | £10.20/mg |
| Pharma Lab Global Canada | 5 mg | £51.54 GBP | £10.31/mg |
| Direct Peptides Canada | 5 mg | £59.99 GBP | £12.00/mg |
| Direct Peptides USA | 5 mg | £59.99 GBP | £12.00/mg |
| Pharma Lab Global Canada | 5 mg | £60.52 GBP | £12.10/mg |
| Direct Peptides Canada | 2 mg | £24.86 GBP | £12.43/mg |
| Direct Peptides USA | 2 mg | £24.86 GBP | £12.43/mg |
| Pharma Lab Global Canada | 2 mg | £25.39 GBP | £12.70/mg |
| Direct Peptides Canada | 2 mg | £33.84 GBP | £16.92/mg |
| Direct Peptides USA | 2 mg | £33.84 GBP | £16.92/mg |
| Pharma Lab Global Canada | 2 mg | £34.37 GBP | £17.18/mg |
| Vendor | Size | Price | Per mg |
|---|---|---|---|
| Canada Steroid Depot | 10 mg | $129.99 CAD | $13.00/mg |
| Pacific Peptides | 10 mg | $155.00 CAD | $15.50/mg |
| Pacific Peptides | 5 mg | $85.00 CAD | $17.00/mg |
| VPeptide Canada | 10 mg | $249.99 CAD | $25.00/mg |
| Core Peptides Canada | 5 mg | $143.03 CAD | $28.61/mg |
| VPeptide Canada | 10 mg | $299.99 CAD | $30.00/mg |
| Northern Peptides | 5 mg | $155.00 CAD | $31.00/mg |
None of these shops lists your destination. Choose “Show all” to see every listing we hold.
Prices are the vendor's own listing, reproduced with the date we read it — never converted between currencies, and compared per milligram only where the vendor states the vial size.